nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Body temperature increased—Cyclosporine—psoriasis	0.000361	0.000361	CcSEcCtD
Gadoversetamide—Abdominal pain—Cyclosporine—psoriasis	0.000361	0.000361	CcSEcCtD
Gadoversetamide—Anxiety—Betamethasone—psoriasis	0.00036	0.00036	CcSEcCtD
Gadoversetamide—Anxiety—Dexamethasone—psoriasis	0.00036	0.00036	CcSEcCtD
Gadoversetamide—Vomiting—Mycophenolic acid—psoriasis	0.000359	0.000359	CcSEcCtD
Gadoversetamide—Discomfort—Dexamethasone—psoriasis	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Discomfort—Betamethasone—psoriasis	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Dyspepsia—Hydrocortisone—psoriasis	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Haemoglobin—Methotrexate—psoriasis	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Rash—Mycophenolic acid—psoriasis	0.000356	0.000356	CcSEcCtD
Gadoversetamide—Dermatitis—Mycophenolic acid—psoriasis	0.000355	0.000355	CcSEcCtD
Gadoversetamide—Pain—Prednisolone—psoriasis	0.000355	0.000355	CcSEcCtD
Gadoversetamide—Haemorrhage—Methotrexate—psoriasis	0.000355	0.000355	CcSEcCtD
Gadoversetamide—Urticaria—Mycophenolate mofetil—psoriasis	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Headache—Mycophenolic acid—psoriasis	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Decreased appetite—Hydrocortisone—psoriasis	0.000353	0.000353	CcSEcCtD
Gadoversetamide—Pharyngitis—Methotrexate—psoriasis	0.000352	0.000352	CcSEcCtD
Gadoversetamide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000352	0.000352	CcSEcCtD
Gadoversetamide—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000352	0.000352	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Methotrexate—psoriasis	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00035	0.00035	CcSEcCtD
Gadoversetamide—Fatigue—Hydrocortisone—psoriasis	0.00035	0.00035	CcSEcCtD
Gadoversetamide—Vision blurred—Prednisone—psoriasis	0.000349	0.000349	CcSEcCtD
Gadoversetamide—Urethral disorder—Methotrexate—psoriasis	0.000348	0.000348	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000348	0.000348	CcSEcCtD
Gadoversetamide—Pain—Hydrocortisone—psoriasis	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Dexamethasone—psoriasis	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Oedema—Betamethasone—psoriasis	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Oedema—Dexamethasone—psoriasis	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Betamethasone—psoriasis	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Insomnia—Triamcinolone—psoriasis	0.000346	0.000346	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Prednisone—psoriasis	0.000343	0.000343	CcSEcCtD
Gadoversetamide—Paraesthesia—Triamcinolone—psoriasis	0.000343	0.000343	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisolone—psoriasis	0.000342	0.000342	CcSEcCtD
Gadoversetamide—Shock—Betamethasone—psoriasis	0.000341	0.000341	CcSEcCtD
Gadoversetamide—Shock—Dexamethasone—psoriasis	0.000341	0.000341	CcSEcCtD
Gadoversetamide—Dyspnoea—Triamcinolone—psoriasis	0.000341	0.000341	CcSEcCtD
Gadoversetamide—Nervous system disorder—Betamethasone—psoriasis	0.00034	0.00034	CcSEcCtD
Gadoversetamide—Nervous system disorder—Dexamethasone—psoriasis	0.00034	0.00034	CcSEcCtD
Gadoversetamide—Agitation—Prednisone—psoriasis	0.00034	0.00034	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Dexamethasone—psoriasis	0.000339	0.000339	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Betamethasone—psoriasis	0.000339	0.000339	CcSEcCtD
Gadoversetamide—Tachycardia—Betamethasone—psoriasis	0.000338	0.000338	CcSEcCtD
Gadoversetamide—Tachycardia—Dexamethasone—psoriasis	0.000338	0.000338	CcSEcCtD
Gadoversetamide—Hypersensitivity—Cyclosporine—psoriasis	0.000336	0.000336	CcSEcCtD
Gadoversetamide—Dyspepsia—Triamcinolone—psoriasis	0.000336	0.000336	CcSEcCtD
Gadoversetamide—Erythema multiforme—Methotrexate—psoriasis	0.000336	0.000336	CcSEcCtD
Gadoversetamide—Nausea—Mycophenolic acid—psoriasis	0.000335	0.000335	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Dexamethasone—psoriasis	0.000335	0.000335	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Betamethasone—psoriasis	0.000335	0.000335	CcSEcCtD
Gadoversetamide—Feeling abnormal—Hydrocortisone—psoriasis	0.000334	0.000334	CcSEcCtD
Gadoversetamide—Malaise—Prednisone—psoriasis	0.000334	0.000334	CcSEcCtD
Gadoversetamide—Vertigo—Prednisone—psoriasis	0.000332	0.000332	CcSEcCtD
Gadoversetamide—Eye disorder—Methotrexate—psoriasis	0.000332	0.000332	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000332	0.000332	CcSEcCtD
Gadoversetamide—Syncope—Prednisone—psoriasis	0.000332	0.000332	CcSEcCtD
Gadoversetamide—Tinnitus—Methotrexate—psoriasis	0.000331	0.000331	CcSEcCtD
Gadoversetamide—Anorexia—Betamethasone—psoriasis	0.00033	0.00033	CcSEcCtD
Gadoversetamide—Anorexia—Dexamethasone—psoriasis	0.00033	0.00033	CcSEcCtD
Gadoversetamide—Urticaria—Prednisolone—psoriasis	0.00033	0.00033	CcSEcCtD
Gadoversetamide—Cardiac disorder—Methotrexate—psoriasis	0.00033	0.00033	CcSEcCtD
Gadoversetamide—Fatigue—Triamcinolone—psoriasis	0.000329	0.000329	CcSEcCtD
Gadoversetamide—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000328	0.000328	CcSEcCtD
Gadoversetamide—Asthenia—Cyclosporine—psoriasis	0.000328	0.000328	CcSEcCtD
Gadoversetamide—Pain—Triamcinolone—psoriasis	0.000327	0.000327	CcSEcCtD
Gadoversetamide—Loss of consciousness—Prednisone—psoriasis	0.000325	0.000325	CcSEcCtD
Gadoversetamide—Hypotension—Dexamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Gadoversetamide—Hypotension—Betamethasone—psoriasis	0.000324	0.000324	CcSEcCtD
Gadoversetamide—Pruritus—Cyclosporine—psoriasis	0.000323	0.000323	CcSEcCtD
Gadoversetamide—Urticaria—Hydrocortisone—psoriasis	0.000322	0.000322	CcSEcCtD
Gadoversetamide—Angiopathy—Methotrexate—psoriasis	0.000322	0.000322	CcSEcCtD
Gadoversetamide—Immune system disorder—Methotrexate—psoriasis	0.000321	0.000321	CcSEcCtD
Gadoversetamide—Abdominal pain—Hydrocortisone—psoriasis	0.000321	0.000321	CcSEcCtD
Gadoversetamide—Body temperature increased—Hydrocortisone—psoriasis	0.000321	0.000321	CcSEcCtD
Gadoversetamide—Convulsion—Prednisone—psoriasis	0.00032	0.00032	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Methotrexate—psoriasis	0.00032	0.00032	CcSEcCtD
Gadoversetamide—Asthenia—Mycophenolate mofetil—psoriasis	0.00032	0.00032	CcSEcCtD
Gadoversetamide—Hypertension—Prednisone—psoriasis	0.000319	0.000319	CcSEcCtD
Gadoversetamide—Chills—Methotrexate—psoriasis	0.000319	0.000319	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000316	0.000316	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000316	0.000316	CcSEcCtD
Gadoversetamide—Pruritus—Mycophenolate mofetil—psoriasis	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Arthralgia—Prednisone—psoriasis	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Myalgia—Prednisone—psoriasis	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Feeling abnormal—Triamcinolone—psoriasis	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Anxiety—Prednisone—psoriasis	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Insomnia—Dexamethasone—psoriasis	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Insomnia—Betamethasone—psoriasis	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000313	0.000313	CcSEcCtD
Gadoversetamide—Diarrhoea—Cyclosporine—psoriasis	0.000312	0.000312	CcSEcCtD
Gadoversetamide—Paraesthesia—Betamethasone—psoriasis	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Paraesthesia—Dexamethasone—psoriasis	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Discomfort—Prednisone—psoriasis	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Mental disorder—Methotrexate—psoriasis	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Malnutrition—Methotrexate—psoriasis	0.000309	0.000309	CcSEcCtD
Gadoversetamide—Erythema—Methotrexate—psoriasis	0.000309	0.000309	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisolone—psoriasis	0.000306	0.000306	CcSEcCtD
Gadoversetamide—Dyspepsia—Dexamethasone—psoriasis	0.000305	0.000305	CcSEcCtD
Gadoversetamide—Dyspepsia—Betamethasone—psoriasis	0.000305	0.000305	CcSEcCtD
Gadoversetamide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000305	0.000305	CcSEcCtD
Gadoversetamide—Urticaria—Triamcinolone—psoriasis	0.000304	0.000304	CcSEcCtD
Gadoversetamide—Dysgeusia—Methotrexate—psoriasis	0.000303	0.000303	CcSEcCtD
Gadoversetamide—Body temperature increased—Triamcinolone—psoriasis	0.000302	0.000302	CcSEcCtD
Gadoversetamide—Dizziness—Cyclosporine—psoriasis	0.000302	0.000302	CcSEcCtD
Gadoversetamide—Oedema—Prednisone—psoriasis	0.000302	0.000302	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisone—psoriasis	0.000302	0.000302	CcSEcCtD
Gadoversetamide—Decreased appetite—Dexamethasone—psoriasis	0.000301	0.000301	CcSEcCtD
Gadoversetamide—Decreased appetite—Betamethasone—psoriasis	0.000301	0.000301	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Betamethasone—psoriasis	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Back pain—Methotrexate—psoriasis	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Hypersensitivity—Hydrocortisone—psoriasis	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Fatigue—Betamethasone—psoriasis	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Fatigue—Dexamethasone—psoriasis	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Shock—Prednisone—psoriasis	0.000297	0.000297	CcSEcCtD
Gadoversetamide—Pain—Dexamethasone—psoriasis	0.000296	0.000296	CcSEcCtD
Gadoversetamide—Pain—Betamethasone—psoriasis	0.000296	0.000296	CcSEcCtD
Gadoversetamide—Nervous system disorder—Prednisone—psoriasis	0.000296	0.000296	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisone—psoriasis	0.000295	0.000295	CcSEcCtD
Gadoversetamide—Dizziness—Mycophenolate mofetil—psoriasis	0.000295	0.000295	CcSEcCtD
Gadoversetamide—Skin disorder—Prednisone—psoriasis	0.000293	0.000293	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisone—psoriasis	0.000292	0.000292	CcSEcCtD
Gadoversetamide—Vision blurred—Methotrexate—psoriasis	0.000291	0.000291	CcSEcCtD
Gadoversetamide—Asthenia—Hydrocortisone—psoriasis	0.000291	0.000291	CcSEcCtD
Gadoversetamide—Vomiting—Cyclosporine—psoriasis	0.00029	0.00029	CcSEcCtD
Gadoversetamide—Rash—Cyclosporine—psoriasis	0.000288	0.000288	CcSEcCtD
Gadoversetamide—Anorexia—Prednisone—psoriasis	0.000288	0.000288	CcSEcCtD
Gadoversetamide—Dermatitis—Cyclosporine—psoriasis	0.000288	0.000288	CcSEcCtD
Gadoversetamide—Pruritus—Hydrocortisone—psoriasis	0.000287	0.000287	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Methotrexate—psoriasis	0.000287	0.000287	CcSEcCtD
Gadoversetamide—Headache—Cyclosporine—psoriasis	0.000286	0.000286	CcSEcCtD
Gadoversetamide—Feeling abnormal—Betamethasone—psoriasis	0.000286	0.000286	CcSEcCtD
Gadoversetamide—Feeling abnormal—Dexamethasone—psoriasis	0.000286	0.000286	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Dexamethasone—psoriasis	0.000283	0.000283	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Betamethasone—psoriasis	0.000283	0.000283	CcSEcCtD
Gadoversetamide—Vomiting—Mycophenolate mofetil—psoriasis	0.000283	0.000283	CcSEcCtD
Gadoversetamide—Hypersensitivity—Triamcinolone—psoriasis	0.000281	0.000281	CcSEcCtD
Gadoversetamide—Rash—Mycophenolate mofetil—psoriasis	0.000281	0.000281	CcSEcCtD
Gadoversetamide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000281	0.000281	CcSEcCtD
Gadoversetamide—Headache—Mycophenolate mofetil—psoriasis	0.000279	0.000279	CcSEcCtD
Gadoversetamide—Malaise—Methotrexate—psoriasis	0.000279	0.000279	CcSEcCtD
Gadoversetamide—Vertigo—Methotrexate—psoriasis	0.000278	0.000278	CcSEcCtD
Gadoversetamide—Diarrhoea—Hydrocortisone—psoriasis	0.000278	0.000278	CcSEcCtD
Gadoversetamide—Urticaria—Dexamethasone—psoriasis	0.000275	0.000275	CcSEcCtD
Gadoversetamide—Urticaria—Betamethasone—psoriasis	0.000275	0.000275	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Prednisone—psoriasis	0.000275	0.000275	CcSEcCtD
Gadoversetamide—Dizziness—Prednisolone—psoriasis	0.000275	0.000275	CcSEcCtD
Gadoversetamide—Asthenia—Triamcinolone—psoriasis	0.000274	0.000274	CcSEcCtD
Gadoversetamide—Abdominal pain—Betamethasone—psoriasis	0.000274	0.000274	CcSEcCtD
Gadoversetamide—Abdominal pain—Dexamethasone—psoriasis	0.000274	0.000274	CcSEcCtD
Gadoversetamide—Body temperature increased—Betamethasone—psoriasis	0.000274	0.000274	CcSEcCtD
Gadoversetamide—Body temperature increased—Dexamethasone—psoriasis	0.000274	0.000274	CcSEcCtD
Gadoversetamide—Insomnia—Prednisone—psoriasis	0.000273	0.000273	CcSEcCtD
Gadoversetamide—Nausea—Cyclosporine—psoriasis	0.000271	0.000271	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisone—psoriasis	0.000271	0.000271	CcSEcCtD
Gadoversetamide—Pruritus—Triamcinolone—psoriasis	0.00027	0.00027	CcSEcCtD
Gadoversetamide—Cough—Methotrexate—psoriasis	0.00027	0.00027	CcSEcCtD
Gadoversetamide—Dizziness—Hydrocortisone—psoriasis	0.000268	0.000268	CcSEcCtD
Gadoversetamide—Convulsion—Methotrexate—psoriasis	0.000268	0.000268	CcSEcCtD
Gadoversetamide—Dyspepsia—Prednisone—psoriasis	0.000266	0.000266	CcSEcCtD
Gadoversetamide—Nausea—Mycophenolate mofetil—psoriasis	0.000265	0.000265	CcSEcCtD
Gadoversetamide—Chest pain—Methotrexate—psoriasis	0.000263	0.000263	CcSEcCtD
Gadoversetamide—Arthralgia—Methotrexate—psoriasis	0.000263	0.000263	CcSEcCtD
Gadoversetamide—Myalgia—Methotrexate—psoriasis	0.000263	0.000263	CcSEcCtD
Gadoversetamide—Decreased appetite—Prednisone—psoriasis	0.000262	0.000262	CcSEcCtD
Gadoversetamide—Rash—Prednisolone—psoriasis	0.000262	0.000262	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisolone—psoriasis	0.000262	0.000262	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000261	0.000261	CcSEcCtD
Gadoversetamide—Fatigue—Prednisone—psoriasis	0.00026	0.00026	CcSEcCtD
Gadoversetamide—Headache—Prednisolone—psoriasis	0.00026	0.00026	CcSEcCtD
Gadoversetamide—Discomfort—Methotrexate—psoriasis	0.00026	0.00026	CcSEcCtD
Gadoversetamide—Constipation—Prednisone—psoriasis	0.000258	0.000258	CcSEcCtD
Gadoversetamide—Vomiting—Hydrocortisone—psoriasis	0.000258	0.000258	CcSEcCtD
Gadoversetamide—Rash—Hydrocortisone—psoriasis	0.000256	0.000256	CcSEcCtD
Gadoversetamide—Dermatitis—Hydrocortisone—psoriasis	0.000256	0.000256	CcSEcCtD
Gadoversetamide—Confusional state—Methotrexate—psoriasis	0.000254	0.000254	CcSEcCtD
Gadoversetamide—Headache—Hydrocortisone—psoriasis	0.000254	0.000254	CcSEcCtD
Gadoversetamide—Dizziness—Triamcinolone—psoriasis	0.000253	0.000253	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Methotrexate—psoriasis	0.000252	0.000252	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisone—psoriasis	0.000249	0.000249	CcSEcCtD
Gadoversetamide—Asthenia—Dexamethasone—psoriasis	0.000249	0.000249	CcSEcCtD
Gadoversetamide—Asthenia—Betamethasone—psoriasis	0.000249	0.000249	CcSEcCtD
Gadoversetamide—Nervous system disorder—Methotrexate—psoriasis	0.000247	0.000247	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Methotrexate—psoriasis	0.000247	0.000247	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Prednisone—psoriasis	0.000247	0.000247	CcSEcCtD
Gadoversetamide—Nausea—Prednisolone—psoriasis	0.000247	0.000247	CcSEcCtD
Gadoversetamide—Pruritus—Dexamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Gadoversetamide—Pruritus—Betamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Gadoversetamide—Skin disorder—Methotrexate—psoriasis	0.000245	0.000245	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Methotrexate—psoriasis	0.000244	0.000244	CcSEcCtD
Gadoversetamide—Vomiting—Triamcinolone—psoriasis	0.000243	0.000243	CcSEcCtD
Gadoversetamide—Nausea—Hydrocortisone—psoriasis	0.000241	0.000241	CcSEcCtD
Gadoversetamide—Rash—Triamcinolone—psoriasis	0.000241	0.000241	CcSEcCtD
Gadoversetamide—Dermatitis—Triamcinolone—psoriasis	0.000241	0.000241	CcSEcCtD
Gadoversetamide—Anorexia—Methotrexate—psoriasis	0.00024	0.00024	CcSEcCtD
Gadoversetamide—Urticaria—Prednisone—psoriasis	0.00024	0.00024	CcSEcCtD
Gadoversetamide—Headache—Triamcinolone—psoriasis	0.000239	0.000239	CcSEcCtD
Gadoversetamide—Body temperature increased—Prednisone—psoriasis	0.000239	0.000239	CcSEcCtD
Gadoversetamide—Abdominal pain—Prednisone—psoriasis	0.000239	0.000239	CcSEcCtD
Gadoversetamide—Diarrhoea—Betamethasone—psoriasis	0.000237	0.000237	CcSEcCtD
Gadoversetamide—Diarrhoea—Dexamethasone—psoriasis	0.000237	0.000237	CcSEcCtD
Gadoversetamide—Hypotension—Methotrexate—psoriasis	0.000236	0.000236	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00023	0.00023	CcSEcCtD
Gadoversetamide—Dizziness—Betamethasone—psoriasis	0.000229	0.000229	CcSEcCtD
Gadoversetamide—Dizziness—Dexamethasone—psoriasis	0.000229	0.000229	CcSEcCtD
Gadoversetamide—Insomnia—Methotrexate—psoriasis	0.000228	0.000228	CcSEcCtD
Gadoversetamide—Nausea—Triamcinolone—psoriasis	0.000227	0.000227	CcSEcCtD
Gadoversetamide—Paraesthesia—Methotrexate—psoriasis	0.000227	0.000227	CcSEcCtD
Gadoversetamide—Dyspnoea—Methotrexate—psoriasis	0.000225	0.000225	CcSEcCtD
Gadoversetamide—Somnolence—Methotrexate—psoriasis	0.000224	0.000224	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisone—psoriasis	0.000222	0.000222	CcSEcCtD
Gadoversetamide—Dyspepsia—Methotrexate—psoriasis	0.000222	0.000222	CcSEcCtD
Gadoversetamide—Vomiting—Betamethasone—psoriasis	0.00022	0.00022	CcSEcCtD
Gadoversetamide—Vomiting—Dexamethasone—psoriasis	0.00022	0.00022	CcSEcCtD
Gadoversetamide—Decreased appetite—Methotrexate—psoriasis	0.000219	0.000219	CcSEcCtD
Gadoversetamide—Rash—Dexamethasone—psoriasis	0.000219	0.000219	CcSEcCtD
Gadoversetamide—Rash—Betamethasone—psoriasis	0.000219	0.000219	CcSEcCtD
Gadoversetamide—Dermatitis—Betamethasone—psoriasis	0.000218	0.000218	CcSEcCtD
Gadoversetamide—Dermatitis—Dexamethasone—psoriasis	0.000218	0.000218	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Methotrexate—psoriasis	0.000218	0.000218	CcSEcCtD
Gadoversetamide—Fatigue—Methotrexate—psoriasis	0.000218	0.000218	CcSEcCtD
Gadoversetamide—Headache—Betamethasone—psoriasis	0.000217	0.000217	CcSEcCtD
Gadoversetamide—Headache—Dexamethasone—psoriasis	0.000217	0.000217	CcSEcCtD
Gadoversetamide—Asthenia—Prednisone—psoriasis	0.000217	0.000217	CcSEcCtD
Gadoversetamide—Pain—Methotrexate—psoriasis	0.000216	0.000216	CcSEcCtD
Gadoversetamide—Pruritus—Prednisone—psoriasis	0.000214	0.000214	CcSEcCtD
Gadoversetamide—Feeling abnormal—Methotrexate—psoriasis	0.000208	0.000208	CcSEcCtD
Gadoversetamide—Diarrhoea—Prednisone—psoriasis	0.000207	0.000207	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Methotrexate—psoriasis	0.000206	0.000206	CcSEcCtD
Gadoversetamide—Nausea—Dexamethasone—psoriasis	0.000206	0.000206	CcSEcCtD
Gadoversetamide—Nausea—Betamethasone—psoriasis	0.000206	0.000206	CcSEcCtD
Gadoversetamide—Urticaria—Methotrexate—psoriasis	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Dizziness—Prednisone—psoriasis	0.0002	0.0002	CcSEcCtD
Gadoversetamide—Body temperature increased—Methotrexate—psoriasis	0.000199	0.000199	CcSEcCtD
Gadoversetamide—Abdominal pain—Methotrexate—psoriasis	0.000199	0.000199	CcSEcCtD
Gadoversetamide—Vomiting—Prednisone—psoriasis	0.000192	0.000192	CcSEcCtD
Gadoversetamide—Rash—Prednisone—psoriasis	0.00019	0.00019	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisone—psoriasis	0.00019	0.00019	CcSEcCtD
Gadoversetamide—Headache—Prednisone—psoriasis	0.000189	0.000189	CcSEcCtD
Gadoversetamide—Hypersensitivity—Methotrexate—psoriasis	0.000186	0.000186	CcSEcCtD
Gadoversetamide—Asthenia—Methotrexate—psoriasis	0.000181	0.000181	CcSEcCtD
Gadoversetamide—Nausea—Prednisone—psoriasis	0.000179	0.000179	CcSEcCtD
Gadoversetamide—Pruritus—Methotrexate—psoriasis	0.000179	0.000179	CcSEcCtD
Gadoversetamide—Diarrhoea—Methotrexate—psoriasis	0.000173	0.000173	CcSEcCtD
Gadoversetamide—Dizziness—Methotrexate—psoriasis	0.000167	0.000167	CcSEcCtD
Gadoversetamide—Vomiting—Methotrexate—psoriasis	0.00016	0.00016	CcSEcCtD
Gadoversetamide—Rash—Methotrexate—psoriasis	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Dermatitis—Methotrexate—psoriasis	0.000159	0.000159	CcSEcCtD
Gadoversetamide—Headache—Methotrexate—psoriasis	0.000158	0.000158	CcSEcCtD
Gadoversetamide—Nausea—Methotrexate—psoriasis	0.00015	0.00015	CcSEcCtD
